[go: up one dir, main page]

BRPI0818541A2 - Processo para a produção de um produto farmacêutico - Google Patents

Processo para a produção de um produto farmacêutico

Info

Publication number
BRPI0818541A2
BRPI0818541A2 BRPI0818541-7A BRPI0818541A BRPI0818541A2 BR PI0818541 A2 BRPI0818541 A2 BR PI0818541A2 BR PI0818541 A BRPI0818541 A BR PI0818541A BR PI0818541 A2 BRPI0818541 A2 BR PI0818541A2
Authority
BR
Brazil
Prior art keywords
production
pharmaceutical product
pharmaceutical
product
Prior art date
Application number
BRPI0818541-7A
Other languages
English (en)
Inventor
Tiejun Diao
Haijun Xu
Original Assignee
Ferring Int Ct Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42082803&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0818541(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CNA2007101860236A external-priority patent/CN101406457A/zh
Priority claimed from GB0805953A external-priority patent/GB0805953D0/en
Application filed by Ferring Int Ct Sa filed Critical Ferring Int Ct Sa
Publication of BRPI0818541A2 publication Critical patent/BRPI0818541A2/pt
Publication of BRPI0818541B1 publication Critical patent/BRPI0818541B1/pt
Publication of BRPI0818541B8 publication Critical patent/BRPI0818541B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
BRPI0818541A 2007-10-12 2008-10-10 composição farmacêutica que compreende grânulos incluindo picossulfato de sódio e bicarbonato de potássio e seu processo para a preparação BRPI0818541B8 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP07254049 2007-10-12
EP07254049.5 2007-10-12
US98054907P 2007-10-17 2007-10-17
US60/980,549 2007-10-17
CN200710186023.6 2007-11-09
CNA2007101860236A CN101406457A (zh) 2007-10-12 2007-11-09 制备药物产品的方法
GB0805953.7 2008-04-01
GB0805953A GB0805953D0 (en) 2008-04-01 2008-04-01 Process for the manufacture of a pharmaceutical product
PCT/IB2008/003199 WO2009047633A2 (en) 2007-10-12 2008-10-10 Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate

Publications (3)

Publication Number Publication Date
BRPI0818541A2 true BRPI0818541A2 (pt) 2015-06-16
BRPI0818541B1 BRPI0818541B1 (pt) 2020-12-29
BRPI0818541B8 BRPI0818541B8 (pt) 2021-05-25

Family

ID=42082803

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818541A BRPI0818541B8 (pt) 2007-10-12 2008-10-10 composição farmacêutica que compreende grânulos incluindo picossulfato de sódio e bicarbonato de potássio e seu processo para a preparação

Country Status (24)

Country Link
US (2) US8481083B2 (pt)
EP (1) EP2207526B1 (pt)
JP (1) JP5654873B2 (pt)
KR (2) KR101330096B1 (pt)
CN (1) CN101820859B (pt)
AU (1) AU2008309287B2 (pt)
BR (1) BRPI0818541B8 (pt)
CA (1) CA2702152A1 (pt)
DK (1) DK2207526T3 (pt)
ES (1) ES2659716T3 (pt)
HR (1) HRP20180215T1 (pt)
HU (1) HUE038174T2 (pt)
IL (1) IL204500A (pt)
JO (1) JO3406B1 (pt)
LT (1) LT2207526T (pt)
MX (1) MX2010003588A (pt)
NZ (1) NZ583899A (pt)
PL (1) PL2207526T3 (pt)
PT (1) PT2207526T (pt)
RU (1) RU2473332C2 (pt)
SI (1) SI2207526T1 (pt)
TW (1) TWI418352B (pt)
WO (1) WO2009047633A2 (pt)
ZA (1) ZA201002131B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE038174T2 (hu) 2007-10-12 2018-09-28 Ferring Int Center Sa Eljárás citromsavat, magnéziumoxidot, káliumbikarbonátot és nátriumpikoszulfátot tartalmazó gyógyszertermék elõállítására, ilyen eljárással elõállított szemcsés gyógyászati készítmény és köztitermékei
KR101155099B1 (ko) * 2012-03-29 2012-06-11 남봉길 장 세척용 조성물의 제조 방법 및 이에 의해 제조된 장 세척용 조성물
ES2717282T3 (es) * 2012-07-27 2019-06-20 Redhill Biopharma Ltd Formulaciones y métodos para fabricar formulaciones para su uso en la evacuación colónica
JP2014224080A (ja) * 2013-05-17 2014-12-04 協和化学工業株式会社 大腸の検査または手術のための処置剤
KR101517520B1 (ko) 2013-08-05 2015-05-04 이희엽 피코황산나트륨 함유 장 세척용 조성물의 제조방법
IN2013MU02911A (pt) * 2013-09-10 2015-07-03 Cadila Healthcare Ltd
KR101420315B1 (ko) * 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
SG11201705092TA (en) * 2015-01-14 2017-07-28 Pfizer Oral delivery product
RU2018105869A (ru) 2015-08-17 2019-09-19 Ферринг Б.В. Жидкие составы, содержащие пикосульфат и цитрат магния
CN105456264B (zh) * 2015-12-03 2018-07-10 广州瑞尔医药科技有限公司 双效缓泻的药物组合物及其制备方法
AR108992A1 (es) 2016-07-08 2018-10-17 Ferring Bv Formulaciones líquidas estabilizadas que contienen picosulfato
US11471447B2 (en) 2019-06-20 2022-10-18 Hetero Labs Limited Stable pharmaceutical product and vessel comprising sodium picosulfate, magnesium oxide and citric acid
WO2021056109A1 (en) * 2019-09-24 2021-04-01 Medisca Pharmaceutique Inc. Gel base composition for compounding into a mucoadhesive delivery system
CN110638786A (zh) * 2019-10-09 2020-01-03 杭州百诚医药科技股份有限公司 一种匹可硫酸钠与枸橼酸、氧化镁的药物组合物及制备方法
CN113648327B (zh) * 2021-08-24 2023-03-28 山东京卫制药有限公司 一种药物组合物及其制备方法
CN115040512B (zh) * 2022-07-28 2023-06-20 苏州中化药品工业有限公司 一种药物组合物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1300969A (en) 1969-03-26 1972-12-29 Organon Nv Novel modified acid crystals and a process for their preparation
JPS5731864A (en) * 1980-08-04 1982-02-20 Teijin Ltd Oral activated carbon microcapsule
US5290962A (en) * 1989-09-06 1994-03-01 Exxon Chemical Patents Inc. Method for preparation of anti-calking coating with pigment therein
GB9011034D0 (en) 1990-05-16 1990-07-04 Programme 3 Patent Holdings Electrochemical cell
US5045459A (en) * 1990-10-05 1991-09-03 Haarmann & Reimer Corp. Method for the production of granular citric acid
US5102682A (en) 1991-01-31 1992-04-07 Kraft General Foods, Inc. Sucrose and fructose-containing food mix and process
US5219598A (en) 1991-11-15 1993-06-15 Kraft General Foods, Inc. Reducing sugar-containing mix and process therefore
EP0724441A1 (en) * 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form
US5498425A (en) * 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative
US5674529A (en) 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
CA2186938A1 (en) 1995-10-18 1997-04-19 Dalip K. Nayyar Dry mix for producing a slush beverage
AUPN634595A0 (en) * 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
DE19962251A1 (de) * 1999-12-22 2001-09-06 Hermes Fabrik Pharm Praeparate Lutschtablette
US6514537B1 (en) * 2000-06-02 2003-02-04 Cumberland Swan Holdings, Inc. Magnesium citrate solution
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US20040115265A1 (en) * 2002-12-11 2004-06-17 Loutfy Benkerrour Multilayered tablet containing pravastatin and aspirin and method
US7758906B2 (en) 2006-01-20 2010-07-20 Kraft Foods Global Brands Llc Thickening system for products prepared with milk
HUE038174T2 (hu) 2007-10-12 2018-09-28 Ferring Int Center Sa Eljárás citromsavat, magnéziumoxidot, káliumbikarbonátot és nátriumpikoszulfátot tartalmazó gyógyszertermék elõállítására, ilyen eljárással elõállított szemcsés gyógyászati készítmény és köztitermékei

Also Published As

Publication number Publication date
WO2009047633A3 (en) 2009-09-03
BRPI0818541B8 (pt) 2021-05-25
KR101381263B1 (ko) 2014-04-04
KR20100072020A (ko) 2010-06-29
KR20130105757A (ko) 2013-09-25
PL2207526T3 (pl) 2018-06-29
US8481083B2 (en) 2013-07-09
US8450338B2 (en) 2013-05-28
ZA201002131B (en) 2010-12-29
KR101330096B1 (ko) 2013-11-15
BRPI0818541B1 (pt) 2020-12-29
NZ583899A (en) 2011-12-22
CN101820859B (zh) 2013-05-01
CN101820859A (zh) 2010-09-01
EP2207526B1 (en) 2017-11-22
TWI418352B (zh) 2013-12-11
TW200924759A (en) 2009-06-16
CA2702152A1 (en) 2009-04-16
HRP20180215T1 (hr) 2018-03-23
HUE038174T2 (hu) 2018-09-28
ES2659716T3 (es) 2018-03-19
US20110104285A1 (en) 2011-05-05
PT2207526T (pt) 2018-01-25
LT2207526T (lt) 2018-02-12
AU2008309287A1 (en) 2009-04-16
RU2473332C2 (ru) 2013-01-27
AU2008309287B2 (en) 2014-10-30
RU2010112483A (ru) 2011-11-20
JP5654873B2 (ja) 2015-01-14
JO3406B1 (ar) 2019-10-20
EP2207526A2 (en) 2010-07-21
SI2207526T1 (en) 2018-04-30
WO2009047633A2 (en) 2009-04-16
US20120015036A1 (en) 2012-01-19
MX2010003588A (es) 2010-04-21
JP2011500549A (ja) 2011-01-06
DK2207526T3 (da) 2018-01-29
IL204500A (en) 2016-07-31

Similar Documents

Publication Publication Date Title
BRPI0818541A2 (pt) Processo para a produção de um produto farmacêutico
BRPI0816253A2 (pt) Processo para a produção de um produto de hidrocarboneto
BR112012001983A2 (pt) processo para a produção de um produto de hidrocarboneto
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI0819631A2 (pt) Processo para a preparação de um produto olefínico
BRPI0720070A2 (pt) Processo para produção de produtos de tecido
BR112012003615A2 (pt) processo para a produção de butadieno
BRPI0810452A2 (pt) Processo para a produção de composições de betume
BRPI0923180A2 (pt) processo para a produção de produtos químicos
BRPI0812064A2 (pt) Formulação farmacêutica, tabletes, e, processo para a produção de uma formulação farmacêutica
BRPI0716663A2 (pt) Processo para produzir um produto de nanopartículas de biopolímero
BRPI1012370A2 (pt) processo para a produção de olefinas
BRPI1008976A2 (pt) Processo para preparar um produto de cacau
BRPI0812304A2 (pt) Processo para a produção de p4o6
BRPI1013296A2 (pt) processo para a produção de polidienos
BRPI0914788A2 (pt) Processo para a produção de um produto intermediário de etexilato de dabigatran
BRPI1014812A2 (pt) Processo para a produção de alacoóis
BRPI0917984A2 (pt) processo em batelada para a produção de poliamidas
BRPI0811644A2 (pt) Processo para a produção de pirazóis
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI0817747A2 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BRPI0815784A2 (pt) Processo para a preparação de 1,2-propanodiol
BR112012005418A2 (pt) processo para a produção de grânulos
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI1007880A2 (pt) processo para a produção de produtos de segurança com várias camadas.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/10/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF